A new approach to RNA sequencing reveals thousands of previously inaccessible RNA fragments in blood plasma that might serve as disease- and organ-specific biomarkers.
A new U-M study assesses the short-term degrees of discomfort associated with prostate MRIs and biopsies, offering insights for future prostate cancer patient care.
Pairing a smartphone to capture retinal images with artificial intelligence to interpret them may help overcome barriers to ophthalmic screening for the disease.
Groundbreaking new research marrying high-intensity focused ultrasound with genetically modified cells may spur bone and soft tissue regeneration.
By capturing more cancer cells than blood draw screening, this device could help doctors understand a tumor’s biology and make decisions about treatment.